232 related articles for article (PubMed ID: 10721767)
1. Effect of thrombopoietin on acute myelogenous leukemia blasts.
Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
[TBL] [Abstract][Full Text] [Related]
2. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
4. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
5. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
6. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
Matsumura I; Ikeda H; Kanakura Y
Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
[TBL] [Abstract][Full Text] [Related]
7. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
8. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.
Corazza F; Hermans C; D'Hondt S; Ferster A; Kentos A; Benoît Y; Sariban E
Blood; 2006 Mar; 107(6):2525-30. PubMed ID: 16317100
[TBL] [Abstract][Full Text] [Related]
9. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia.
Hirai H; Shimazaki C; Yamagata N; Goto H; Inaba T; Kikuta T; Sumikuma T; Sudo Y; Ashihara E; Fujita N; Hibi S; Imashuku S; Ito E; Nakagawa M
Eur J Haematol; 1997 Jul; 59(1):38-46. PubMed ID: 9260579
[TBL] [Abstract][Full Text] [Related]
10. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Ishikawa J; Horikawa Y; Hashimoto K; Moriyama Y; Tsujimura T; Nishiura T
Blood; 1995 Jul; 86(2):703-9. PubMed ID: 7541672
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blasts.
Wetzler M; Bernstein SH; Baumann H; Fries KM; Stewart C; Blumenson L; Baer MR; Herzig GP; Bloomfield CD; Slack JL
Leuk Lymphoma; 1998 Aug; 30(5-6):415-31. PubMed ID: 9711904
[TBL] [Abstract][Full Text] [Related]
12. Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia.
Motoji T; Takanashi M; Motomura S; Wang WH; Shiozaki H; Aoyama M; Mizoguchi H
Br J Haematol; 1996 Sep; 94(3):513-6. PubMed ID: 8790152
[TBL] [Abstract][Full Text] [Related]
13. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
[TBL] [Abstract][Full Text] [Related]
14. Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and TPO.
Murayama T; Imoto S; Natazuka T; Chihara K; Matsui T
Leuk Res; 1998 Jun; 22(6):557-60. PubMed ID: 9678722
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia.
Akashi K; Harada M; Shibuya T; Eto T; Takamatsu Y; Teshima T; Niho Y
Blood; 1991 Jul; 78(1):197-204. PubMed ID: 1712640
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
[TBL] [Abstract][Full Text] [Related]
18. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
Drexler HG; Zaborski M; Quentmeier H
Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
[TBL] [Abstract][Full Text] [Related]
20. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
